| Nuvalent: Promising Data Keeps Validating Pipeline And Platform | 09/23 12:34 | seekingalpha.com |
| Nuvalent Announces Closing of Upsized Public Offering of Common Stock | 09/18 16:05 | prnewswire.com |
| Nuvalent Stock Moves Up 20% in a Week: What's Driving the Rally? | 09/18 15:31 | zacks.com |
| Nuvalent: NSCLC Program Now Lends Credibility Towards 2025 Pivotal Data Releases | 09/17 13:20 | seekingalpha.com |
| Nuvalent Announces Pricing of Upsized Public Offering of Common Stock | 09/16 22:23 | prnewswire.com |
| Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity | 09/16 13:44 | benzinga.com |
| Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths | 09/16 13:05 | investors.com |
| Cancer Biotech Nuvalent's Stock Jumps on Positive Data | 09/16 11:18 | barrons.com |
| Nuvalent Announces Public Offering of Common Stock | 09/16 07:00 | prnewswire.com |
| Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines | 09/14 05:00 | prnewswire.com |